158.96
                                            Ishares Biotechnology Etf Borsa (IBB) Ultime notizie
Biotech ETFs Hovering Around a 52-Week: Here's Why - TradingView
Analyst Explains Why He’s Investing in This Top Biotech ETF - Insider Monkey
StockWatch: Top 3 Biotech ETFs Finally Bounce Back with the Market - Genetic Engineering and Biotechnology News
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - sharewise.com
IBB: Biotech's Leading Players, All In One ETF (NASDAQ:IBB) - Seeking Alpha
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - sharewise.com
Biotech ETFs Bounce Back in 2025: Here's Why - TradingView
ISHARES TRUST (^IBB) stock price, news, quote and history - Yahoo
Should You Invest in the iShares Biotechnology ETF (IBB)? - MSN
SciSparc Expands Biotech Ambitions, Buys Stake In Miza III Ventures - Benzinga
iShares TrustiShares Biotechnology ETF (IBB.SN) latest stock news and headlines - Yahoo
Enpro Moves To Boost Profits With $280 Million Acquisition Push - Benzinga
VanEck Biotech ETF (BBH): How to Buy - The Motley Fool
Destiny Wealth Sells $8.1 Million in IBB Shares — Here’s Why Biotech Stocks Are Lagging - The Motley Fool
How Trump's Shutdown Standoff Could Hand Health-Care ETFs A Lifeline - Benzinga
SciSparc And AutoMax Call Off Merger - Sahm
iShares Biotechnology ETF (NQ: - FinancialContent
The Best Biotech ETFs to Buy - Kiplinger
How to Invest in the Entire Biotechnology Industry Through One ETF? - NAI500
Best Biotech ETFs to Watch Right Now - The Motley Fool
How to Invest in iShares Biotechnology ETF (IBB) - The Motley Fool
iShares Biotechnology ETF (IBB) Stock Price, News, Quote & History - Yahoo
iShares Nasdaq Biotechnology ETF declares quarterly distribution of $0.0828 - MSN
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - sharewise.com
Biotech Sector May Flip to Market Leader by Year-End - MarketBeat
Trump's Biotech Playbook Ignites $350 Billion Investment Blitz - Benzinga
iShares Nasdaq Biotechnology ETF declares quarterly distribution of $0.2005 - MSN
BBH vs. IBB: How to Position for the Next Biotech Growth Cycle - AInvest
BBH Vs. IBB: How To Prepare For The Next Biotech Growth Cycle With BBH (NASDAQ:IBB) - Seeking Alpha
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? - Yahoo Finance
(08/22/25) IBB and XBI: Are These Biotech ETFs Worth Trading Here? - moneyshow.com
Healthcare Stocks Move In Different Directions On Key News - Finimize
Bio-Techne Stock: Analyst Estimates & Ratings - NewsBreak: Local News & Alerts
The Longevity Dividend: How Financial Institutions Are Pioneering the Future of Retirement and Healthspan Investing - AInvest
Healthcare Sector's Attractive Valuations and Structural Resilience in a Post-Pandemic Recovery - AInvest
Solar, biotech, and health insurance stocks are moving on Friday: here's why - TheStreet
Stock Market: This Eye Treatment Stock Sees Sales Spike 152% As Biotech Leaders Shine - Investor's Business Daily
The Vaccine Hesitancy Dilemma: How Political and Social Hostility Threaten Biotech and Pharma Equities - AInvest
Biotech And Pharma Stocks Rally After Positive News And Upgrades - Finimize
ARKK Inflows Stay Hot - ETF.com
7 Best Biotech ETFs to Buy Now - US News Money
The Silver Dividend: Unlocking Longevity-Driven Investment Opportunities in Healthspan, AI, and Age-Friendly Infrastructure - AInvest
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - sharewise.com
The Silver Dividend: Strategic Investments in Longevity Technologies and Age-Friendly Sectors for 2025 and Beyond - AInvest
The Longevity Dividend: Investing in the Future of Healthspan Extension - AInvest
Unlocking the Longevity Dividend: Growth Stocks for the Age of Extended Lifespans - AInvest
BIO assets in stake since beginning, accumulating XP for token launch with $205,000 FDV. - AInvest
The Silver Dividend: How Aging Populations Can Drive Economic Growth and Longevity-Linked Investment Opportunities - AInvest
The Silent Crisis: Aging Populations and the Retirement Security Imperative - AInvest
        Apri su Yahoo
        |
        Apri su Google
            |
            Aperto in Finviz
        |
        Apri in MarketWatch
            |
            Aperto a EDGAR    
        |
        Aperto su Reuters
    
    
                Capitalizzazione:
                 
                  | 
                Volume (24 ore):
                 
            
         
                     
                             Scarica l'app Stockscreener
                    Scarica l'app Stockscreener
                